Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancerAnnika Jögi(Lund University), Sara Alkner(Lund University)PLoS ONEDecember 10, 201910.1371/journal.pone.0226150Cited by 72SaveCiteExport RISWatch citationsRelated PapersNuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer|Modern Pathology|2009|85HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells|Oncotarget|2016|22Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer|PLoS ONE|2016|11